Next 10 |
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will be available on the Companyȁ...
2024-04-11 15:56:04 ET Summary The FDA advisory committee voted 12-2 in favor of imetelstat's clinical profile in lower-risk myelodysplastic syndromes. The PDUFA target date for GERN's imetelstat NDA is June 16, 2024. An interim analysis in GERN's IMpactMF study in myelofibros...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences: 23 rd Annual Needham Virtual Health...
2024-03-19 09:21:13 ET More on Geron Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron surges a...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritten offering consisting of 41,999,998 shares of its common stock at a price of $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of its common stock. Th...
2024-03-18 05:21:00 ET 3 Hot Tips for Choosing the Right Penny Stocks to Buy Navigating the realm of penny stocks can unlock pathways to significant financial growth, presenting a landscape ripe with opportunities for those astute enough to capitalize on them. Central to achieving succe...
2024-03-17 10:45:34 ET 3 Tips for Capitalizing on Market Cycles to Make Money With Penny Stocks Capitalizing on market cycles offers a strategic advantage in trading penny stocks, enabling investors to navigate through volatility and harness opportunities for significant returns. Unders...
2024-03-17 08:31:29 ET Friday saw an unprecedented surge in the stock of Geron Corporation (NASDAQ:GERN), with shares ending the day up a staggering 92%. This surge, marking a historic milestone for the company, was ignited by a momentous announcement earlier in the day. An FDA advi...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...
2024-03-15 12:52:05 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Solidion Technology climbs 10% on $3.85M private placement Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Financial i...
News, Short Squeeze, Breakout and More Instantly...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will be available on the Companyȁ...
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday&r...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO). "It's just too risky...